The treatment of wet age-related macular degeneration.

The treatment of wet age-related macular degeneration.

Item
http://www.wikidata.org/entity/Q37527988
Screening and Treatment in Retinopathy of PrematurityRanibizumab for the treatment of degenerative ocular conditions.Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization.Angiogenin in age-related macular degenerationBevacizumab modulates retinal pigment epithelial-to-mesenchymal transition via regulating Notch signaling.Rap1 GTPase Inhibits Tumor Necrosis Factor-α-Induced Choroidal Endothelial Migration via NADPH Oxidase- and NF-κB-Dependent Activation of Rac1.TNF-α mediates choroidal neovascularization by upregulating VEGF expression in RPE through ROS-dependent β-catenin activationTherapies for neovascular age-related macular degeneration: current approaches and pharmacologic agents in development.
P2860

The treatment of wet age-related macular degeneration.

Item
http://www.wikidata.org/entity/Q37527988
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The treatment of wet age-related macular degeneration.
@en
The treatment of wet age-related macular degeneration.
@nl
type
label
The treatment of wet age-related macular degeneration.
@en
The treatment of wet age-related macular degeneration.
@nl
prefLabel
The treatment of wet age-related macular degeneration.
@en
The treatment of wet age-related macular degeneration.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
The treatment of wet age-related macular degeneration.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932